These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Endovascular Versus Medical Management of Atherosclerotic Renovascular Disease: Update and Emerging Concepts. Pappaccogli M; Robberechts T; Lengelé JP; Van der Niepen P; Sarafidis P; Rabbia F; Persu A Hypertension; 2023 Jun; 80(6):1150-1161. PubMed ID: 36919595 [TBL] [Abstract][Full Text] [Related]
28. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553 [TBL] [Abstract][Full Text] [Related]
29. Indication for intervention in patients with renovascular hypertension. Vaughan ED; Case DB; Pickering TG; Sosa RE; Sos TA; Laragh JH Am J Kidney Dis; 1985 Apr; 5(4):A136-43. PubMed ID: 3158195 [TBL] [Abstract][Full Text] [Related]
30. Renovascular Hypertension with Progressive Atherosclerotic Renal Artery Stenosis in an Elderly Patient with Known Fibromuscular Dysplasia: A Case Report. Alex J; Rajpurohit D; Zughaib M Am J Case Rep; 2023 May; 24():e939881. PubMed ID: 37210595 [TBL] [Abstract][Full Text] [Related]
31. [Renovascular hypertension: is it only the top of the iceberg?]. Lewandowski J Pol Merkur Lekarski; 2003 Oct; 15(88):371-5; discussion 375-6. PubMed ID: 14974369 [TBL] [Abstract][Full Text] [Related]